Cargando…

Sickle Cell Disease in Jordan: The Experience of a Major Referral Center

INTRODUCTION: Sickle cell disorders are the most frequently encountered hemoglobin variants in Jordan. Both alpha and beta thalassemias are also prevalent in this population. However, studies on the interaction between these hemoglobin disorders are lacking. AIM: To determine the genotypes responsib...

Descripción completa

Detalles Bibliográficos
Autores principales: Oudat, Raida I., Abualruz, Heba S., Al-Shiek, Nazih KH. Abu, AL-Mashaqba, Eman A., AL-Hiari, Rawan A., Alsoukhni, Hala A., Hammad, Ma’mon A. Abu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Academy of Medical Sciences of Bosnia and Herzegovina 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8116085/
https://www.ncbi.nlm.nih.gov/pubmed/34012195
http://dx.doi.org/10.5455/medarh.2021.75.27-30
_version_ 1783691317218377728
author Oudat, Raida I.
Abualruz, Heba S.
Al-Shiek, Nazih KH. Abu
AL-Mashaqba, Eman A.
AL-Hiari, Rawan A.
Alsoukhni, Hala A.
Hammad, Ma’mon A. Abu
author_facet Oudat, Raida I.
Abualruz, Heba S.
Al-Shiek, Nazih KH. Abu
AL-Mashaqba, Eman A.
AL-Hiari, Rawan A.
Alsoukhni, Hala A.
Hammad, Ma’mon A. Abu
author_sort Oudat, Raida I.
collection PubMed
description INTRODUCTION: Sickle cell disorders are the most frequently encountered hemoglobin variants in Jordan. Both alpha and beta thalassemias are also prevalent in this population. However, studies on the interaction between these hemoglobin disorders are lacking. AIM: To determine the genotypes responsible for Sickle cell disease in Jordan, by retrospectively reviewing the data from a major referral center in the country’s capital. METHODS: A total 29,712 peripheral blood samples referred and investigated for hemoglobinopathies over a 10-year period at Princess Iman Center at Amman, Jordan were retrospectively reviewed. In addition to full blood counts, high performance liquid chromatography, those who were identified with sickle cell hemoglobin were studied using polymerase chain reaction and reverse hybridization to determine the various sickle cell disease genotypes. RESULTS: Out of the (29,712) blood samples, 450 were sickle cell trait, while 216 had sickle cell disease. Of the latter: 120 were found to be cases of Sickle cell anemia (Hb SS), 66 were compound heterozygous for Sickle cell and a beta thalassemia mutation (Sickle/β-thalassemia), while 30 had concomitant alpha thalassemia (HbSS/alpha thalassemia). The most frequent genotype associated with sickle/β-thalassemia was HbS/ IVS-110 (G>A), followed by Hb S/IVS-I-6 (T>C), HbS/IVS-II-745 (C>G) and HbS/ IVS-II-1 (G>A). While the most frequent alpha genotype detected in HbSS/α-thalassemia samples was (-α(3.7)/αα) followed by (-α(3.7)/-α(3.7)). Hb SS patients had the severest hematological phenotype compared to those with sickle/β-thalassemia and sickle/ α-thalassemia. Furthermore, within the sickle/β-thalassemia subgroup the least severe hematological phenotype was encountered in HbS/IVS-1-6 (T>C), while the most severe in HbS/IVS-II-1 (G>A) genotype. CONCLUSION: The most frequent Sickle cell disease genotype in Jordanians is Sickle cell anemia (HbSS), followed by Sickle/β-thalassemia and least frequent is HbSS/alpha thalassemia. The concomitant identified thalassemia mutations were consistent with their spectrum among the Jordanian population.
format Online
Article
Text
id pubmed-8116085
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Academy of Medical Sciences of Bosnia and Herzegovina
record_format MEDLINE/PubMed
spelling pubmed-81160852021-05-18 Sickle Cell Disease in Jordan: The Experience of a Major Referral Center Oudat, Raida I. Abualruz, Heba S. Al-Shiek, Nazih KH. Abu AL-Mashaqba, Eman A. AL-Hiari, Rawan A. Alsoukhni, Hala A. Hammad, Ma’mon A. Abu Med Arch Original Paper INTRODUCTION: Sickle cell disorders are the most frequently encountered hemoglobin variants in Jordan. Both alpha and beta thalassemias are also prevalent in this population. However, studies on the interaction between these hemoglobin disorders are lacking. AIM: To determine the genotypes responsible for Sickle cell disease in Jordan, by retrospectively reviewing the data from a major referral center in the country’s capital. METHODS: A total 29,712 peripheral blood samples referred and investigated for hemoglobinopathies over a 10-year period at Princess Iman Center at Amman, Jordan were retrospectively reviewed. In addition to full blood counts, high performance liquid chromatography, those who were identified with sickle cell hemoglobin were studied using polymerase chain reaction and reverse hybridization to determine the various sickle cell disease genotypes. RESULTS: Out of the (29,712) blood samples, 450 were sickle cell trait, while 216 had sickle cell disease. Of the latter: 120 were found to be cases of Sickle cell anemia (Hb SS), 66 were compound heterozygous for Sickle cell and a beta thalassemia mutation (Sickle/β-thalassemia), while 30 had concomitant alpha thalassemia (HbSS/alpha thalassemia). The most frequent genotype associated with sickle/β-thalassemia was HbS/ IVS-110 (G>A), followed by Hb S/IVS-I-6 (T>C), HbS/IVS-II-745 (C>G) and HbS/ IVS-II-1 (G>A). While the most frequent alpha genotype detected in HbSS/α-thalassemia samples was (-α(3.7)/αα) followed by (-α(3.7)/-α(3.7)). Hb SS patients had the severest hematological phenotype compared to those with sickle/β-thalassemia and sickle/ α-thalassemia. Furthermore, within the sickle/β-thalassemia subgroup the least severe hematological phenotype was encountered in HbS/IVS-1-6 (T>C), while the most severe in HbS/IVS-II-1 (G>A) genotype. CONCLUSION: The most frequent Sickle cell disease genotype in Jordanians is Sickle cell anemia (HbSS), followed by Sickle/β-thalassemia and least frequent is HbSS/alpha thalassemia. The concomitant identified thalassemia mutations were consistent with their spectrum among the Jordanian population. Academy of Medical Sciences of Bosnia and Herzegovina 2021-02 /pmc/articles/PMC8116085/ /pubmed/34012195 http://dx.doi.org/10.5455/medarh.2021.75.27-30 Text en © 2021 Raida I. Oudat, Heba S. Abualruz, Nazih KH. Abu Al-Shiek, Eman A. AL-Mashaqba, Rawan A. AL-Hiari, Hala A. Alsoukhni, Ma’mon A. Abu Hammad https://creativecommons.org/licenses/by-nc/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) ) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Paper
Oudat, Raida I.
Abualruz, Heba S.
Al-Shiek, Nazih KH. Abu
AL-Mashaqba, Eman A.
AL-Hiari, Rawan A.
Alsoukhni, Hala A.
Hammad, Ma’mon A. Abu
Sickle Cell Disease in Jordan: The Experience of a Major Referral Center
title Sickle Cell Disease in Jordan: The Experience of a Major Referral Center
title_full Sickle Cell Disease in Jordan: The Experience of a Major Referral Center
title_fullStr Sickle Cell Disease in Jordan: The Experience of a Major Referral Center
title_full_unstemmed Sickle Cell Disease in Jordan: The Experience of a Major Referral Center
title_short Sickle Cell Disease in Jordan: The Experience of a Major Referral Center
title_sort sickle cell disease in jordan: the experience of a major referral center
topic Original Paper
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8116085/
https://www.ncbi.nlm.nih.gov/pubmed/34012195
http://dx.doi.org/10.5455/medarh.2021.75.27-30
work_keys_str_mv AT oudatraidai sicklecelldiseaseinjordantheexperienceofamajorreferralcenter
AT abualruzhebas sicklecelldiseaseinjordantheexperienceofamajorreferralcenter
AT alshieknazihkhabu sicklecelldiseaseinjordantheexperienceofamajorreferralcenter
AT almashaqbaemana sicklecelldiseaseinjordantheexperienceofamajorreferralcenter
AT alhiarirawana sicklecelldiseaseinjordantheexperienceofamajorreferralcenter
AT alsoukhnihalaa sicklecelldiseaseinjordantheexperienceofamajorreferralcenter
AT hammadmamonaabu sicklecelldiseaseinjordantheexperienceofamajorreferralcenter